Total Utang marang Modal Renovaro Inc. (RENB)

Renovaro Inc. - logo grafis emiten RENB

Renovaro Inc. (RENB) is creating a high-tech personalized therapy cycle where AI-driven big data analytics are combined with the production of cellular vaccines for early tumor detection, establishing significant barriers to entry for competitors. The price trend relative to the debt-to-equity ratio is 0.08. The business relies on outsourcing molecule synthesis and testing through CRO partners while maintaining full control over its intellectual property.

Renovaro Biosciences (RENB): Rasio Utang marang Ekuitas saka 21.02.2024 nganti 01.10.2025

Rincian metrik lan analitis perusahaan Renovaro (RENB)

- rega saham lan konsensus proyeksi valuasi:
Rega saham Renovaro Biosciences|RENB - Target konsensus
- rincian kapitalisasi pasar:
Kapitalisasi pasar Renovaro|RENB - Nilai Perusahaan
- indikator kapitalisasi buku:
Aset Bersih saben Siji Saham Renovaro|RENB - Kapitalisasi Akuntansi|Rasio Kapitalisasi Pasar marang Nilai Buku renovarobio.com|RENB - Gunggung Aset Perusahaan
- rincian utang lan likuiditas:
Total Utang marang Modal Renovaro Inc.|RENB - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas Renovaro Biosciences|RENB - Kewajiban utang agregat|Utang marang nilai buku Renovaro|RENB - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Renovaro|Indikator likuiditas cepet renovarobio.com
- data bathi resik lan rasio valuasi:
RENB - Bathi resik
Pambiji fundamental perusahaan:Renovaro Inc.
Produk dadi Renovaro Biosciences

The stability of Renovaro Inc. (RENB) depends on its ability to fund costly developments in AI diagnostics and oncology without excessive debt load. By analyzing the total debt-to-equity ratio, an investor can see the proportion of borrowed funds relative to equity assets, which allows for an assessment of insolvency risk and the impact of leverage on the fair market value of the business.

Analisis pesaing Renovaro Inc.

ONC (BeiGene) - Total Utang marang Modal|Rasio Total Utang marang Ekuitas Halozyme Therapeutics, Inc. (HALO)|Total Utang marang Modal RVMD|Total Utang marang Modal Ascentage Pharma Corp (AAPG)|Utang marang Ekuitas CG Oncology, Inc. CGON|URGN: Rasio Utang marang Ekuitas|Bicara Therapeutics - Total Utang marang Modal|Personalis Inc (PSNL) - Rasio Total Utang marang Ekuitas|ERAS: Total Utang marang Modal|Utang marang Modal Delcath Corp (DCTH)|Utang marang Ekuitas Y-mAbs Therapeutics|AURA: Rasio Kabeh Utang marang Dana Pribadi|Rasio Total Utang marang Ekuitas CADL (Candel Therapeutics)|ARAY (Accuray Inc) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal SLS (SELLAS Life Sciences Group)|ACTU - Rasio Total Utang marang Ekuitas|CTOR: Rasio Total Utang marang Ekuitas|HURA - Total Utang marang Modal|Protara Therapeutics, Inc. (TARA) - Utang marang Ekuitas|Fate Therapeutics Inc - Rasio Kabeh Utang marang Dana Pribadi|WHWK (Aadi Bioscience, Inc.) - Total Utang marang Modal|Utang marang Modal TScan TCRX|Utang marang Ekuitas Champions Oncology (CSBR)|XBIT (xbiotech.com) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal CVM (CEL-SCI)|OS Therapies Inc. (OSTX) - Utang marang Modal|RADX - Utang marang Ekuitas|ARTV (Artiva Biotherapeutics, Inc.) - Rasio Utang marang Ekuitas|adlainortye.com (ANL) - Utang marang Ekuitas|Utang marang Modal verupharma.com (VERU)|Rasio Total Utang marang Ekuitas TPST|Utang marang Ekuitas XLO|Total Utang marang Modal MURA|Total Utang marang Modal kairospharma.com (KAPA)|Utang marang Ekuitas OnKure Therapeutics OKUR|Rasio Kabeh Utang marang Dana Pribadi GDTC|CRIS - Utang marang Ekuitas|Utang marang Modal Apollomics, Inc.|THAR (Tharimmune Corp) - Rasio Total Utang marang Ekuitas|Advanced Biomed - Rasio Kabeh Utang marang Dana Pribadi|GNPX (Genprex, Inc.) - Total Utang marang Modal|Calidi Bio (CLDI) - Koefisien Total Utang marang Modal|Utang marang Ekuitas Sunshine Biopharma, Inc. (SBFM)|xeneticbio.com - Rasio Utang marang Ekuitas|Total Utang marang Modal SLRX (Salarius)|PPBT - Rasio Total Utang marang Ekuitas|AONC: Rasio Total Utang marang Ekuitas|Koefisien Total Utang marang Modal beigene.com BGNE|Checkpoint Therapeutics, Inc. (CKPT) - Utang marang Ekuitas|elevationoncology.com - Rasio Kabeh Utang marang Dana Pribadi|ICAD (iCAD Inc.) - Total Utang marang Modal|Utang marang Modal Ikena IKNA|Utang marang Ekuitas Notable Labs, Ltd. (NTBL)|viracta.com - Rasio Utang marang Ekuitas|Total Utang marang Modal MOR (MorphoSys)|NAYA Biosciences Inc - Utang marang Ekuitas|Ascentage Pharma Group Ltd - Total Utang marang Modal